@article{20685,
  author = {Ryden L. and Tardif J. and Nicholls S. and Grobbee D. and Lincoff A. and Malmberg K. and Buse J. and Henry R. and Wedel H. and Weichert A. and Cannata R. and Schwartz G. and Svensson A. and Volz D. and AleCardio Investigators and Neal Bruce},
  title = {Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial},
  year = {2014},
  journal = {Journal of the American Medical Association (JAMA)},
  volume = {311},
  edition = {30 March 2014},
  number = {15},
  pages = {1515-25},
  isbn = {1538-3598 (Electronic) - 0098-7484 (Linking)},
  note = {Lincoff, A Michael<br/>Tardif, Jean-Claude<br/>Schwartz, Gregory G<br/>Nicholls, Stephen J<br/>Ryden, Lars<br/>Neal, Bruce<br/>Malmberg, Klas<br/>Wedel, Hans<br/>Buse, John B<br/>Henry, Robert R<br/>Weichert, Arlette<br/>Cannata, Ruth<br/>Svensson, Anders<br/>Volz, Dietmar<br/>Grobbee, Diederick E<br/>AleCardio Investigators<br/>Clinical Trial, Phase III<br/>Multicenter Study<br/>Randomized Controlled Trial<br/>Research Support, Non-U.S. Gov't<br/>United States<br/>JAMA. 2014 Apr 16;311(15):1515-25. doi: 10.1001/jama.2014.3321.},
  language = {eng},
}